Rea, D., Gray, R., Bowden, S., Handley, K., Earl, H., Poole, C., . . . Lee, M. (2013). Overall and subgroup findings of the aTTom trial: A randomised comparison of continuing adjuvant tamoxifen to 10 years compared to stopping after 5 years in 6953 women with ER positive or ER untested early breast cancer.
Čikaški stil citiranja (17. izdanje)Rea, D., et al. Overall and Subgroup Findings of the ATTom Trial: A Randomised Comparison of Continuing Adjuvant Tamoxifen to 10 Years Compared to Stopping After 5 Years in 6953 Women with ER Positive or ER Untested Early Breast Cancer. 2013.
MLA način citiranja (9. izdanje)Rea, D., et al. Overall and Subgroup Findings of the ATTom Trial: A Randomised Comparison of Continuing Adjuvant Tamoxifen to 10 Years Compared to Stopping After 5 Years in 6953 Women with ER Positive or ER Untested Early Breast Cancer. 2013.